M/13/021 – Aspen / MSD NL 8 B.V.
The acquisition of MSD NL 8 B.V. (a subsidiary of Merck & Co Incorporated) by Aspen Pharmacare Holdings Limited has been cleared by the Competition Authority.
|Notification date||Decision date|
|Thursday July 18, 2013||Wednesday, August 14, 2013|
|Parties Involved||Business activities|
|Aspen Pharmacare Holdings Limited||
Aspen is a globally competitive producer of high quality affordable generic medicines and is involved in the development, registration, manufacture, import, marketing, selling and distribution of pharmaceutical products.
|MSD NL 8 B.V.||
MSD BV is comprised of the API manufacturing business which manufactures unprocessed APIs both for Merck and Co Incorporated and the market generally.
|Economic sector||Media merger|
|The pharmaceutical industry||No|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Monday, July 29, 2013|
|Current status: Completed|
|Cleared (Phase 1)|
|Authorised Officer Assigned||Contact Details|
Tel: 01-804 5420
Media enquiries: MKC Communications: 01 7038600